COVID-19 vaccine responses to be studied in people with immune deficits
Canada reaches deal with Pfizer for vaccines in future years
23 April 2021Global experts define how to assess quality of care for patients with atrial fibrillation
24 April 2021COVID-19 vaccine responses to be studied in people with immune deficits
A study assessing how people with immune system deficiencies or dysregulations respond to COVID-19 vaccination has begun enrolling participants at the National Institutes of Health Clinical Center in Bethesda, Maryland. The single-site study is led by researchers from the National Institute of Allergy and Infectious Diseases (NIAID) and aims to enroll 500 people, 400 with primary or secondary immune system disorders and 100 without such conditions.
